No. grade IV (%) 68 (44) 31 (72) No. oligodendroglial (%) 7 (5) 0 (0) No. mixed histology (%) 44 (28) 0 (0) No. astrocytic (%) 105 (67) 43 (100) No. I-A (%) 47 (30) 12 (28) Mean age at diagnosis ± S.D., years 35 ± 8 30 ± 5
Median survival, months 59 43
No. I-X (%) 70 (45) 30 (70) Mean age at diagnosis ± S.D., years 56 ± 14 50 ± 14
Median survival, months 17 11
No. I-CF (%) 39 (25) 1 (2) Mean age at diagnosis ± S.D., years 43 ± 13 53
Median survival, months 94 N.R.
*Cohort A was from Duke University Medical Center, United States. Cohort B was from the University of Sao Paulo, Brazil. 
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